Palantir’s PE ratio is still an eye-popping 600x earnings — but with earnings doubling year-over-year and strong defense contracts in play, is the valuation really out of line? MarketBeat’s Chris Markoch shares his latest outlook on Palantir, why its commercial growth story matters as much as its go
2 extracted signals · 2 resolved · 0 still active
MarketBeatIndependent analyst profile- Source published
- 17 Aug 2025, 23:14 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC

AI-generated source summary
The video discusses Palantir (PLTR), currently at $177.14, with analysts setting a $200 price target within 12 months. It notes potential market slowdowns affecting growth and advises investors on buy-in points post sell-offs. It is mentioned that a pullback wouldn’t be driven by Palantir's fundamentals but influenced by market trends. BigBear.ai, a competitor in the defense sector, reported that earnings are not in line with expectations. For investors already holding Palantir stock, there is a discussion on whether to take profits or wait for a potential price dip and re-enter. It highlights the shift in defense spending toward technological advancements and suggests Rocket Lab (RKLB) as a relevant defense and space sector company to monitor for growth opportunities. Investors should consider the risk of new and smaller tech and defense players. The video identifies Palantir's support at $154.17 and $147.58, if it reaches that point they recommend to add stock back. It indicates the potential for Palantir to continue to thrive.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
2 eligible signals linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
MarketBeat
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

